Can the risk of developing chronic liver disease be predicted? Pfizer and Atostek’s research studies the potential of Kanta data for automated disease risk identification
Pfizer, one of the world's largest pharmaceutical companies, wanted to explore whether the risk of developing chronic liver disease could be predicted using Finland's national health information database, Kanta. Atostek studied the potential for secondary use of Kanta data in…